Showing 501-510 of 1043 results for "".
About the Cover Artist
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/about-the-cover-artist-8/31882/Maria Sammartino immersed herself in the arts after her diagnosis with multiple sclerosis.Neuroimmunomodulation & COVID-19
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuroimmunomodulation-covid-19/31743/Use of immunotherapies for neurologic conditions in the COVID-19 era is a double-edged sword.Genetic Testing in Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/genetic-testing-in-neuromuscular-disorders/31549/Understanding ordering and interpretation of genetic tests is paramount for clinical management.Wellness and Neurology
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/wellness-and-neurology/30155/There is clear evidence for promoting wellness practices to all patients with neurologic disorders.Seeking Breakthroughs: The Startup Perspective
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-startup-perspective/30194/A roundtable discussion with Chase Spurlock, PhD, IQuity; Michal Izrael, PhD, Kadimastem Ltd; Kevin Hrusovsky, Quanterix; and J. Michael Ryan, MD, Rodin TherapeuticsNeuroAdvocacy: Why Lobbying Matters
https://practicalneurology.com/columns/practice-management/neuroadvocacy-why-lobbying-matters/30328/Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.In-Focus: TBI
https://practicalneurology.com/diseases-diagnoses/tbi/in-focus-tbi/30337/Security First: A Guide to Teleneurology Platforms
https://practicalneurology.com/columns/practice-management/security-first-a-guide-to-teleneurology-platforms/30380/Busy Alzheimer's Pipeline Offers Hope for Significant Treatment Advances
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/busy-alzheimers-pipeline-offers-hope-for-significant-treatment-advances/30440/One expert explains why Alzheimer's research and therapeutics are poised for major gains over the next decade.In-Focus: Communication
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/in-focus-communication/30461/